143. Psychedelics for Palliative care with Prof Robert Schoevers

·28 min·2 clips

Patients were trying to stay in control—the opposite of what they should do.

Professor Robert Schoevers discusses his research on psychedelic therapies, starting with ketamine for treatment-resistant depression and moving to psilocybin studies. He shares insights from clinical trials, including failures and breakthroughs, and introduces the PSYPAR project exploring psychedelics for palliative care.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Drug Science Podcast